The effect of Resveratrol and Octreotide on peritoneal adhesions in a rat model. 2018

O Üreyen, and M A Üstuner, and A Argon, and M Özbilgin, and T Egeli, and E Ìlhan, and E Vardar, and T Ünek, and M Yildirim, and N Erkan
Ìzmir Bozyaka Education and Research Hospital, Department of General Surgery, Ìzmir, Turkey. orhan.ureyen@saglik.gov.tr.

BACKGROUND The aim of this study was to investigate the efficacy of resveratrol and octreotide, agents that are used to prevent intra-abdominal adhesions in experimental models, in preventing intraperitoneal adhesions when used alone or in combination. METHODS The study employed 28 young female Wistar albino rats weighing 250-300 grams. An experimental adhesion model was created in each rat using serosal abrasion and peritoneal excision. They were divided into four groups, each comprising seven rats: Group 1, adhesion induction only; Group 2, resveratrol administration only; Group 3, octreotide administration only; and Group 4, administration of resveratrol and octreotide combination. The rats were monitored under appropriate conditions for 14 days and then underwent laparotomy. Macroscopic intensity and extensiveness of adhesions and microscopic changes in the granulation tissue (cellular intensity, reticular and collagen fibers, capillaries, elastic and smooth muscle fibers, fibrosis) were evaluated and graded. Kruskal-Wallis and Mann-Whitney U-test were used in statistical analysis and the level of statistical significance was established as p <0.05. RESULTS There was no significant difference between the groups in terms of the intensity and extensiveness of macroscopic adhesions (p=0.377 and p=0.319). There was a statistically significant difference between the microscopic scores of the groups according to Zühlke's classification (p=0.026). The Bonferroni correction used to test for the differences revealed that the rats in Group 1 achieved significantly higher scores than the rats in Group 3 (p=0.016). CONCLUSIONS Octreotide showed higher efficiency compared to the control group in microscopic classification; however, the two agents were not superior to each other or their combination was not superior in preventing intra-abdominal adhesions.

UI MeSH Term Description Entries
D010532 Peritoneal Diseases Pathological processes involving the PERITONEUM. Peritoneal Disease
D010537 Peritoneum A membrane of squamous EPITHELIAL CELLS, the mesothelial cells, covered by apical MICROVILLI that allow rapid absorption of fluid and particles in the PERITONEAL CAVITY. The peritoneum is divided into parietal and visceral components. The parietal peritoneum covers the inside of the ABDOMINAL WALL. The visceral peritoneum covers the intraperitoneal organs. The double-layered peritoneum forms the MESENTERY that suspends these organs from the abdominal wall. Parietal Peritoneum,Peritoneum, Parietal,Peritoneum, Visceral,Visceral Peritoneum,Parametrium,Parametriums
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000077185 Resveratrol A stilbene and non-flavonoid polyphenol produced by various plants including grapes and blueberries. It has anti-oxidant, anti-inflammatory, cardioprotective, anti-mutagenic, and anti-carcinogenic properties. It also inhibits platelet aggregation and the activity of several DNA HELICASES in vitro. 3,4',5-Stilbenetriol,3,4',5-Trihydroxystilbene,3,5,4'-Trihydroxystilbene,Resveratrol, (Z)-,Resveratrol-3-sulfate,SRT 501,SRT-501,SRT501,cis-Resveratrol,trans-Resveratrol,trans-Resveratrol-3-O-sulfate,Resveratrol 3 sulfate,cis Resveratrol,trans Resveratrol,trans Resveratrol 3 O sulfate
D000267 Tissue Adhesions Pathological processes consisting of the union of the opposing surfaces of a wound. Adhesions, Tissue,Surgery-Induced Tissue Adhesions,Surgical Adhesions,Adhesion, Surgery-Induced Tissue,Adhesion, Surgical,Adhesion, Tissue,Adhesions, Surgery-Induced Tissue,Adhesions, Surgical,Surgery Induced Tissue Adhesions,Surgery-Induced Tissue Adhesion,Surgical Adhesion,Tissue Adhesion,Tissue Adhesion, Surgery-Induced,Tissue Adhesions, Surgery-Induced
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015282 Octreotide A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula. Octreotide Acetate,Compound 201-995,Octreotide Acetate Salt,SAN 201-995,SM 201-995,SMS 201-995,Sandostatin,Sandostatine,Sandoz 201-995,Compound 201 995,Compound 201995,SAN 201 995,SAN 201995,SM 201 995,SM 201995,SMS 201 995,SMS 201995,Sandoz 201 995,Sandoz 201995
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

O Üreyen, and M A Üstuner, and A Argon, and M Özbilgin, and T Egeli, and E Ìlhan, and E Vardar, and T Ünek, and M Yildirim, and N Erkan
January 2007, Cell biochemistry and function,
O Üreyen, and M A Üstuner, and A Argon, and M Özbilgin, and T Egeli, and E Ìlhan, and E Vardar, and T Ünek, and M Yildirim, and N Erkan
September 2007, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
O Üreyen, and M A Üstuner, and A Argon, and M Özbilgin, and T Egeli, and E Ìlhan, and E Vardar, and T Ünek, and M Yildirim, and N Erkan
December 2016, Acta chirurgica Belgica,
O Üreyen, and M A Üstuner, and A Argon, and M Özbilgin, and T Egeli, and E Ìlhan, and E Vardar, and T Ünek, and M Yildirim, and N Erkan
March 2020, European journal of obstetrics, gynecology, and reproductive biology,
O Üreyen, and M A Üstuner, and A Argon, and M Özbilgin, and T Egeli, and E Ìlhan, and E Vardar, and T Ünek, and M Yildirim, and N Erkan
January 2019, Evidence-based complementary and alternative medicine : eCAM,
O Üreyen, and M A Üstuner, and A Argon, and M Özbilgin, and T Egeli, and E Ìlhan, and E Vardar, and T Ünek, and M Yildirim, and N Erkan
December 2002, Pediatric surgery international,
O Üreyen, and M A Üstuner, and A Argon, and M Özbilgin, and T Egeli, and E Ìlhan, and E Vardar, and T Ünek, and M Yildirim, and N Erkan
July 1996, Scandinavian journal of gastroenterology,
O Üreyen, and M A Üstuner, and A Argon, and M Özbilgin, and T Egeli, and E Ìlhan, and E Vardar, and T Ünek, and M Yildirim, and N Erkan
November 2004, American journal of surgery,
O Üreyen, and M A Üstuner, and A Argon, and M Özbilgin, and T Egeli, and E Ìlhan, and E Vardar, and T Ünek, and M Yildirim, and N Erkan
January 2012, Journal of bodywork and movement therapies,
O Üreyen, and M A Üstuner, and A Argon, and M Özbilgin, and T Egeli, and E Ìlhan, and E Vardar, and T Ünek, and M Yildirim, and N Erkan
January 1982, Archives of gynecology,
Copied contents to your clipboard!